| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |